by Sara M. Nolte | Feb 14, 2020
We’ve spent a lot of time swooning over CAR T-cells and CRISPR here at Signals, but recently a potential up-and-coming leading lady in the gene and cancer therapy fields has caught our eye. Our interest was piqued by a recent press release from The Max Delbruck Center...
by Tara Fernandez | Oct 17, 2019
RNA-based vaccines have been heralded as a new molecular weapon in the arsenal against cancer and infections. Five years ago, they were thrust into the spotlight following a $52 million investment by the Bill and Melinda Gates Foundation to CureVac, a...
by Stacey Johnson | Oct 26, 2018
It’s heartbreaking to watch this February 2018 video of Jonathan Pitre, the Canadian teen with epidermolysis bullosa (EB), who advocated for patients and fought so hard to be rid of his disease, and sadly died two months after the video below was published. He was the...
by Stacey Johnson | Sep 28, 2018
September is National Blood Cancer Awareness Month. “Few people know that many of today’s fundamental treatments for various cancers, like chemotherapy, began with blood cancer research,” explains Alicia Talarico, President, Leukemia & Lymphoma...
by Sowmya Viswanathan | Jun 26, 2018
Debe Griffin, MSc, ASQ CPGP, has over 20 years of experience in the cell therapy field, both in bench positions and in leadership. Her primary interests are process improvement, quality assurance and regulatory affairs. She is a consultant with FACT Consulting...
Comments